Literature DB >> 10747174

Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile.

A P Limaye1, D K Turgeon, B T Cookson, T R Fritsche.   

Abstract

We report a case of severe pseudomembranous colitis due to a toxin A(-) B(+) strain of Clostridium difficile in an immunosuppressed patient and discuss the implications for diagnostic testing in suspected C. difficile-associated diarrhea.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10747174      PMCID： PMC86532     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains.

Authors:  H Kato; N Kato; S Katow; T Maegawa; S Nakamura; D M Lyerly
Journal:  FEMS Microbiol Lett       Date:  1999-06-15       Impact factor: 2.742

2.  An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital.

Authors:  A al-Barrak; J Embil; B Dyck; K Olekson; D Nicoll; M Alfa; A Kabani
Journal:  Can Commun Dis Rep       Date:  1999-04-01

3.  Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease.

Authors:  G P Bongaerts; D M Lyerly
Journal:  Microb Pathog       Date:  1997-04       Impact factor: 3.738

Review 4.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 5.  Pseudomembranous colitis: causes and cures.

Authors:  C M Surawicz; L V McFarland
Journal:  Digestion       Date:  1999 Mar-Apr       Impact factor: 3.216

6.  Multicenter evaluation of the Clostridium difficile TOX A/B TEST.

Authors:  D M Lyerly; L M Neville; D T Evans; J Fill; S Allen; W Greene; R Sautter; P Hnatuck; D J Torpey; R Schwalbe
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 7.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

8.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Authors:  D M Lyerly; L A Barroso; T D Wilkins; C Depitre; G Corthier
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 9.  The diagnosis of Clostridium difficile-associated disease.

Authors:  J S Brazier
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

10.  Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.

Authors:  H Kato; N Kato; K Watanabe; N Iwai; H Nakamura; T Yamamoto; K Suzuki; S M Kim; Y Chong; E B Wasito
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948
  10 in total
  32 in total

Review 1.  Clostridium difficile testing: after 20 years, still challenging.

Authors:  Tracy D Wilkins; David M Lyerly
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.

Authors:  A Lozniewski; C Rabaud; E Dotto; M Weber; F Mory
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Evaluation of two rapid immunochromatography tests for the detection of Clostridium difficile toxins.

Authors:  Zmira Samra; Avia Luzon; Jihad Bishara
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

5.  Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin.

Authors:  John R Ticehurst; Deborah Z Aird; Lisa M Dam; Anita P Borek; John T Hargrove; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

6.  Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro.

Authors:  Benedito A Carneiro; Jun Fujii; Gerly A C Brito; Cirle Alcantara; Reinaldo B Oriá; Aldo A M Lima; Tom Obrig; Richard L Guerrant
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.

Authors:  David K Turgeon; Thomas J Novicki; John Quick; LaDonna Carlson; Pat Miller; Bruce Ulness; Anne Cent; Rhoda Ashley; Ann Larson; Marie Coyle; Ajit P Limaye; Brad T Cookson; Thomas R Fritsche
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea.

Authors:  William Braunlin; Qiuwei Xu; Patrick Hook; Richard Fitzpatrick; Jeffrey D Klinger; Robert Burrier; Caroline B Kurtz
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

9.  High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.

Authors:  M Komatsu; H Kato; M Aihara; K Shimakawa; M Iwasaki; Y Nagasaka; S Fukuda; S Matsuo; Y Arakawa; M Watanabe; Y Iwatani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

Review 10.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.